Brief: Chr. Hansen Q1 Adj. EBIT Slightly Below Consensus
Jan 12 (Reuters) - Chr. Hansen Q1 revenue EUR 310 million vs. estimate EUR 307 million. * Q1 organic growth 10% vs. estimate 8.4% * Q1 net income EUR 49.5 million vs. estimate EUR 55 million * Q1 adjusted EBIT EUR 77 million vs. estimate EUR 78 million * Q1 adjusted EBIT margin 24.7% vs. estimate 25.5% * Outlook FY organic growth 7-10% (unchanged) * Outlook FY adjusted EBIT margin 26-27% (previously 27-28%) * Outlook FY adjusted free cash flow EUR 170-210 million (previously EURm 190-230)
Recent news on Chr Hansen Holding A/S
See all newsJefferies sees above peer growth for Novozymes, ups to 'buy'
Brief: Combination Of Novozymes, Chr. Hansen Is Completed
Brief: Novozymes Says All Necessary Regulatory Approvals Obtained For Combination Novozymes And Chr. Hansen
European Commission clears Novozymes, Chr. Hansen merger (updated)
European Commission clears Novozymes, Chr. Hansen merger